BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31799751)

  • 1. Comparison of the functional and structural characteristics of rare TSC2 variants with clinical and genetic findings.
    Dufner Almeida LG; Nanhoe S; Zonta A; Hosseinzadeh M; Kom-Gortat R; Elfferich P; Schaaf G; Kenter A; Kümmel D; Migone N; Povey S; Ekong R; Nellist M
    Hum Mutat; 2020 Apr; 41(4):759-773. PubMed ID: 31799751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive genetic and phenotype analysis of 95 individuals with mosaic tuberous sclerosis complex.
    Klonowska K; Giannikou K; Grevelink JM; Boeszoermenyi B; Thorner AR; Herbert ZT; Afrin A; Treichel AM; Hamieh L; Kotulska K; Jozwiak S; Moss J; Darling TN; Kwiatkowski DJ
    Am J Hum Genet; 2023 Jun; 110(6):979-988. PubMed ID: 37141891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of TSC1 and TSC2 in Danish patients with tuberous sclerosis complex.
    Rosengren T; Nanhoe S; de Almeida LGD; Schönewolf-Greulich B; Larsen LJ; Hey CAB; Dunø M; Ek J; Risom L; Nellist M; Møller LB
    Sci Rep; 2020 Jun; 10(1):9909. PubMed ID: 32555378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variants Within TSC2 Exons 25 and 31 Are Very Unlikely to Cause Clinically Diagnosable Tuberous Sclerosis.
    Ekong R; Nellist M; Hoogeveen-Westerveld M; Wentink M; Panzer J; Sparagana S; Emmett W; Dawson NL; Malinge MC; Nabbout R; Carbonara C; Barberis M; Padovan S; Futema M; Plagnol V; Humphries SE; Migone N; Povey S
    Hum Mutat; 2016 Apr; 37(4):364-70. PubMed ID: 26703369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the TSC2 GAP Domain: Mechanistic Insight into Catalysis and Pathogenic Mutations.
    Hansmann P; Brückner A; Kiontke S; Berkenfeld B; Seebohm G; Brouillard P; Vikkula M; Jansen FE; Nellist M; Oeckinghaus A; Kümmel D
    Structure; 2020 Aug; 28(8):933-942.e4. PubMed ID: 32502382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics, genomics, and genotype-phenotype correlations of TSC: Insights for clinical practice.
    Peron A; Au KS; Northrup H
    Am J Med Genet C Semin Med Genet; 2018 Sep; 178(3):281-290. PubMed ID: 30255984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional assessment of TSC2 variants identified in individuals with tuberous sclerosis complex.
    Hoogeveen-Westerveld M; Ekong R; Povey S; Mayer K; Lannoy N; Elmslie F; Bebin M; Dies K; Thompson C; Sparagana SP; Davies P; van Eeghen AM; Thiele EA; van den Ouweland A; Halley D; Nellist M
    Hum Mutat; 2013 Jan; 34(1):167-75. PubMed ID: 22903760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analysis of 18 families with tuberous sclerosis complex.
    Yin K; Lin N; Lu Q; Jin L; Huang Y; Zhou X; Xu K; Liu Q; Zhang X
    Neurogenetics; 2022 Jul; 23(3):223-230. PubMed ID: 35596872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of TSC1 and TSC2 genes in Tuberous Sclerosis Complex patients from Greece.
    Avgeris S; Fostira F; Vagena A; Ninios Y; Delimitsou A; Vodicka R; Vrtel R; Youroukos S; Stravopodis DJ; Vlassi M; Astrinidis A; Yannoukakos D; Voutsinas GE
    Sci Rep; 2017 Dec; 7(1):16697. PubMed ID: 29196670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First comprehensive TSC1/TSC2 mutational analysis in Mexican patients with Tuberous Sclerosis Complex reveals numerous novel pathogenic variants.
    Reyna-Fabián ME; Hernández-Martínez NL; Alcántara-Ortigoza MA; Ayala-Sumuano JT; Enríquez-Flores S; Velázquez-Aragón JA; Varela-Echavarría A; Todd-Quiñones CG; González-Del Angel A
    Sci Rep; 2020 Apr; 10(1):6589. PubMed ID: 32313033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype-phenotype correlation of patients with tuberous sclerosis complex-associated renal angiomyolipoma: a descriptive study.
    Li S; Zhang Y; Wang Z; Yang Y; Gao W; Li D; Wei J
    Hum Pathol; 2018 Dec; 82():61-67. PubMed ID: 30036593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild TSC phenotype and non-penetrance associated with a frameshift variant in TSC2 prompts caution in evaluating pathogenicity of frameshift variants.
    Farach LS; Northrup H; Nellist M; van Unen L; Hillman P; Klonowska K; Ekong R; Crino PB; Au KS
    Gene; 2023 Aug; 877():147566. PubMed ID: 37311496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Architecture of the Tuberous Sclerosis Protein Complex.
    Ramlaul K; Fu W; Li H; de Martin Garrido N; He L; Trivedi M; Cui W; Aylett CHS; Wu G
    J Mol Biol; 2021 Jan; 433(2):166743. PubMed ID: 33307091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberous Sclerosis Complex in Chinese patients: Phenotypic analysis and mutational screening of TSC1/TSC2 genes.
    Lin S; Zeng JB; Zhao GX; Yang ZZ; Huang HP; Lin MT; Wu ZY; Wang N; Chen WJ; Fang L
    Seizure; 2019 Oct; 71():322-327. PubMed ID: 31525612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline mutation of TSC1 or TSC2 gene in Chinese patients with bilateral renal angiomyolipomas and mutation spectrum of Chinese TSC patients.
    Jiangyi W; Gang G; Guohai S; Dingwei Y
    Aging (Albany NY); 2020 Jan; 12(1):756-766. PubMed ID: 31927531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSC2 pathogenic variants are predictive of severe clinical manifestations in TSC infants: results of the EPISTOP study.
    Ogórek B; Hamieh L; Hulshof HM; Lasseter K; Klonowska K; Kuijf H; Moavero R; Hertzberg C; Weschke B; Riney K; Feucht M; Scholl T; Krsek P; Nabbout R; Jansen AC; Benova B; Aronica E; Lagae L; Curatolo P; Borkowska J; Sadowski K; Domańska-Pakieła D; Janson S; Kozlowski P; Urbanska M; Jaworski J; Jozwiak S; Jansen FE; Kotulska K; ; Kwiatkowski DJ
    Genet Med; 2020 Sep; 22(9):1489-1497. PubMed ID: 32461669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a Novel TSC2 c.170G>A Missense Variant: A Case Report and Elaboration on the Yield of Targeted Options against Tuberous Sclerosis Complex Manifestations.
    Papageorgiou G; Skouteris N; Valavanis C; Stanc GM; Souka E; Charalampakis N
    Rev Recent Clin Trials; 2023; 18(4):304-312. PubMed ID: 37877150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights into TSC complex assembly and GAP activity on Rheb.
    Yang H; Yu Z; Chen X; Li J; Li N; Cheng J; Gao N; Yuan HX; Ye D; Guan KL; Xu Y
    Nat Commun; 2021 Jan; 12(1):339. PubMed ID: 33436626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between epilepsy and genotype: A large retrospective tuberous sclerosis complex cohort.
    Ding Y; Zhou Y; Yu L; Zhang L; Zhou S; Wang Y; Wang J
    Seizure; 2021 Oct; 91():273-277. PubMed ID: 34252879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep phenotyping of patients with Tuberous Sclerosis Complex and no mutation identified in TSC1 and TSC2.
    Peron A; Vignoli A; Briola F; Morenghi E; Tansini L; Alfano RM; Bulfamante G; Terraneo S; Ghelma F; Banderali G; Viskochil DH; Carey JC; Canevini MP;
    Eur J Med Genet; 2018 Jul; 61(7):403-410. PubMed ID: 29432982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.